From: Risk of venous occlusion after lead laser extraction preventing future lead implantation
Total | Venous occlusion group | Control Group | |
---|---|---|---|
Patients | n = 219 | 13 | 26 |
Age | 65 ± 14 | 57 ± 17 | 61 ± 18 |
Sex, % male (n = 163) | 74.4 | 4.5 (10) | 6.8 (15) |
Body mass index | 27.6 ± 10.5 | 25.0 ± 5.6 | 26.8 ± 4.4 |
Diabetes mellitus, % (n) | 31.9% (70) | 1.36 (3) | 3.65 (8) |
EF, % | 42.05 ± 14.5 | 40.8 ± 16.0 | 34.9 ± 10.1 |
NYHA functional class III | 62 (28.3%) | 1.5 ± 0.8 | 2.1 ± 0.9 |
Coronary artery disease | 106 (48.4%) | 4 (1.8%) | 14 (6.4%) |
Arterial hypertension | 187 (85.4%) | 11 (5.0%) | 24 (10.9%) |
Renal insufficiency | 28 (12.8%) | 0 | 5 (2.2%) |
ICD | 162 (73.97%) | 10 (4.5%) | 22 (10.0%) |